Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ronald Grey is active.

Publication


Featured researches published by Ronald Grey.


Bioorganic & Medicinal Chemistry Letters | 2015

Benzimidazole-containing HCV NS5A inhibitors: effect of 4-substituted pyrrolidines in balancing genotype 1a and 1b potency.

James A. Henderson; Darius Bilimoria; Monica Bubenik; Caroline Cadilhac; Kevin M. Cottrell; Evelyne Dietrich; Francois Denis; Nigel Ewing; Guy Falardeau; Simon Giroux; Ronald Grey; Lucille L’Heureux; Bingcan Liu; Nagraj Mani; Mark Morris; Olivier Nicolas; Oswy Z. Pereira; Carl Poisson; B. Govinda Rao; T. Jagadeeswar Reddy; Subajini Selliah; Rebecca S. Shawgo; Louis Vaillancourt; Jian Wang; Constantin Yannopoulos; Nathalie Chauret; Francoise Berlioz-Seux; Laval C. Chan; Sanjoy Kumar Das; Anne-Laure Grillot

The treatment of HCV with highly efficacious, well-tolerated, interferon-free regimens is a compelling clinical goal. Trials employing combinations of direct-acting antivirals that include NS5A inhibitors have shown significant promise in meeting this challenge. Herein, we describe our efforts to identify inhibitors of NS5A and report on the discovery of benzimidazole-containing analogs with subnanomolar potency against genotype 1a and 1b replicons. Our SAR exploration of 4-substituted pyrrolidines revealed that the subtle inclusion of a 4-methyl group could profoundly increase genotype 1a potency in multiple scaffold classes.


Archive | 2003

Diaminotriazoles useful as inhibitors of protein kinases

Albert Pierce; Michael J. Arnost; Robert J. Davies; Cornelia J. Forster; Vincent Galullo; Ronald Grey; Mark Ledeboer; Shi-Kai Tian; Jinwang Xu; Hayley Binch; Brian Ledford; David Messersmith; Suganthi Nanthakumar; Andrew Jayaraj; Greg Henkel; Francesco Salituro; Jian Wang


Archive | 2007

c-MET protein kinase inhibitors for the treatment of proliferative disorders

David J. Lauffer; Robert J. Davies; Dean Stamos; Alexander Aronov; David D. Deininger; Ronald Grey; Jinwang Xu; Pan Li; Brian Ledford; Luc J. Farmer; Randy S. Bethiel; Dylan Jacobs; Kira Mcginty


Archive | 2004

Aminotriazole compounds useful as inhibitors of protein kinases

Michael J. Arnost; Guy W. Bemis; Robert J. Davies; Cornelia J. Forster; Ronald Grey; Mark Ledeboer; Brian Ledford; Craig Marhefka; David Messersmith; Albert Pierce; Francesco Salituro; Jian Wang


Archive | 2010

Isoindolinone inhibitors of phosphatidylinositol 3-kinase

Alex Aronov; Jon H. Come; Robert J. Davies; Albert Pierce; Jian Wang; Suganthini Nanthakumar; Jingrong Cao; Upul K. Bandarage; Elaine Krueger; Amaud Le Tiran; Yusheng Liao; David Messersmith; Philip N. Collier; Ronald Grey; Hardwin O'dowd; James A. Henderson; Anne-Laure Grillot


Archive | 2003

Triazolopyridazines as protein kinases inhibitors

Jeremy Green; Ronald Grey; Albert Pierce


Archive | 2008

C-met protein kinase inhibitors

David J. Lauffer; Robert J. Davies; Dean Stamos; Alexander Aronov; David D. Deininger; Ronald Grey; Jinwang Xu; Pan Li; Brian Ledford; Luc J. Farmer; Randy S. Bethiel; Dylan Jacobs; Kira Mcginty


Archive | 2012

Benzimidazole analogues for the treatment or prevention of flavivirus infections

James A. Henderson; John Maxwell; Louis Vaillancourt; Mark Morris; Ronald Grey; Simon Giroux; Laval Chan Chun Kong; Sanjoy Kumar Das; Bingcan Liu; Carl Poisson; Caroline Cadilhac; Monica Bubenik; T. Jagadeeswar Reddy; Guy Falardeau; Constantin Yannopoulos; Jian Wang; Oswy Z. Pereira; Youssef L. Bennani; Albert Pierce; Govinda Rao Bhisetti; Kevin M. Cottrell; Valerie Marone


Archive | 2018

AMINOTRIAZOLES POUR TRAITER DES MALADIES DÉMYÉLINISANTES

Randy S. Bethiel; Jingrong Cao; Collier, Philip, N.; Robert J. Davies; Elisabeth Doyle; James Daniel Frantz; Brian Anthony Goldman; Ronald Grey; Anne-Laure Grillot; Wenxin Gu; Adrianne Lynne Kolpak; Paul Eduardo Krauss; Yusheng Liao; Sanjay Shivayogi Magavi; David Messersmith; Emanuele Perola; Ryu, Elizabeth, Jin-Sun; Joshua Syken; Jian Wang


Archive | 2017

inibidores isoindolinona de fosfatidilinositol 3-quinase

Albert Pierce; Alex Aronov; Amaud Le Tiran; Anne Laure Grillot; David Messersmith; Elaine Krueger; Hardwin O'dowd; James A. Henderson; Jian Wang; Jingrong Cao; Jon Come; Philip N. Collier; Robert J. Davies; Ronald Grey; Suganthini Nanthakumar; Upul K. Bandarage; Yusheng Liao

Collaboration


Dive into the Ronald Grey's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jian Wang

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jinwang Xu

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge